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Abstract
: The mammalian endoplasmic reticulum (ER) continuouslyBackground
adapts to the cellular secretory load by the activation of an unfolded protein
response (UPR).  This stress response results in expansion of the ER,
upregulation of proteins involved in protein folding and degradation, and
attenuation of protein synthesis.  The response is orchestrated by three
signalling pathways each activated by a specific signal transducer, either
inositol requiring enzyme α (IRE1α), double-stranded RNA-activated protein
kinase-like ER kinase (PERK) or activating transcription factor 6 (ATF6).
 Activation of IRE1α results in its oligomerisation, autophosphorylation and
stimulation of its ribonuclease activity.  The ribonuclease initiates the splicing of
an intron from mRNA encoding the transcription factor, X-box binding protein 1
(XBP1), as well as degradation of specific mRNAs and microRNAs.
: To investigate the consequence of expression of exogenous XBP1,Methods
we generated a stable cell-line expressing spliced XBP1 mRNA under the
control of an inducible promotor.
: Following induction of expression, high levels of XBP1 protein wereResults
detected, which allowed upregulation of target genes in the absence of
induction of the UPR.  Remarkably under stress conditions, the expression of
exogenous XBP1 repressed splicing of endogenous XBP1 mRNA without
repressing the activation of PERK.
: These results illustrate that a feedback mechanism exists toConclusions
attenuate Ire1α ribonuclease activity in the presence of XBP1.
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Introduction
The endoplasmic reticulum (ER) is the site of protein folding and 
post-translational modification of secreted and transmembrane 
proteins1. Under stress conditions such as glucose starvation or a 
viral infection, the folding capacity of the ER can become com-
promised, leading to a potentially lethal build-up of unfolded or 
misfolded proteins2. Protein folding homeostasis can be restored 
by triggering of a stress response called the unfolded protein 
response (UPR)3. This complex and tightly-regulated process has 
downstream effects that enable the ER to adapt to stress conditions, 
and if this pro-survival strategy does not successfully restore ER 
homeostasis then pro-apoptotic signalling is induced4.
The mammalian UPR is formed from three distinct but 
overlapping signalling branches, each governed by an initial effec-
tor protein localised to the ER membrane. These proteins are 
activating transcription factor 6 (ATF6), protein kinase-like ER 
kinase (PERK) and inositol requiring enzyme α (IRE1α), and 
are activated in the presence of a build-up of incorrectly folded 
proteins5. Of these three mammalian UPR effectors, IRE1α is the 
most conserved with its yeast homolog being solely responsible 
for the UPR in lower eukaryotes6. The activation of its cytosolic 
endoribonuclease (RNase) domain enables processing of unspliced 
X-box binding protein 1 (XBP1) mRNA (XBP1u). Spliced 
transcripts (XBP1s) are translated into the protein XBP1S, a 
transcription factor that upregulates the expression of proteins 
involved in ER protein folding, ER associated degradation 
(ERAD) and lipid biogenesis as part of a concerted effort to 
increase the capacity of the ER to cope with unfolded proteins.
In addition to its RNase domain, IRE1α also contains a cytosolic 
kinase domain and a lumenal domain that senses ER stress, 
and these domains are connected by a single transmembrane 
domain7. Upon activation, IRE1α forms dimers8, via ‘face-to-face’ 
interactions9. The ‘face-to-face’ dimer displays no RNase activ-
ity and represents an early stage in IRE1α activation; its main 
purpose is to bring the kinase domains into proximity to enable 
transautophosphorylation. Phosphorylation induces a change in 
structure into a ‘back-to-back’ dimer9, which brings the RNase 
domains into direct contact, forming a functional RNase active 
site capable of splicing XBP1u.
Activated IRE1α is also able to digest mRNAs10 and miRNAs11 
during a process termed Regulated IRE1α Dependent Decay 
(RIDD). It has been suggested that the specificity of IRE1α 
changes during the UPR, initially cleaving XBP1u, but during 
prolonged stress switching to the cleavage of mRNA coding for 
proteins upregulated during the UPR. The consequence is an 
exacerbation of the stress leading to apoptosis12. In addition, 
the cleavage of miRNAs responsible for the downregulation of 
caspase-2 results in elevated levels of this protease and induction 
of apoptosis through the BAX/BAK-dependent pathway11. What 
regulates this switch in specificity is unknown, but could be 
related to subtle changes in IRE1α phosphorylation status, 
conformation or interaction with IRE1α regulators13.
Given the potential for IRE1α to activate proapoptotic factors 
during prolonged ER stress, it is important to understand how 
IRE1α activity is attenuated. Previous studies indicate that this 
attenuation may be the result of multiple mechanisms to reduce 
IRE1α protein, reverse oligomerisation or alter phosphoryla-
tion status. For example, IRE1α transcripts can be degraded by 
RIDD14 and activated IRE1α dimers can be dephosphorylated by 
the phosphatase PP2Ce15. In addition, the oxidation of thiols within 
the IRE1α lumenal domain occurs during activation, a modifica-
tion that is reversed during IRE1α attenuation. This mechanism of 
attenuation is dependent upon oxidoreductase activity provided by 
P5, a member of the protein disulfide isomerase family16. Finally 
the depletion of XBP1S can be facilitated by XBP1U, the protein 
translated from XBP1u transcripts, and involves the binding of 
XBP1U to XBP1S and subsequent trafficking to the 26S proteasome 
for degradation17.
In order to explore the regulatory mechanisms of IRE1α, we 
investigated the impact of high levels of expression of XBP1S 
on the activity of IRE1α. Our results show that an abundance of 
XBP1S represses endogenous XBP1 splicing during unstressed and 
stress conditions. This repression may represent a regulatory mech-
anism, where persistent ER stress attenuates IRE1α RNase activity 
at least towards XBP1 mRNA.
Materials and methods
Generation of stable cell lines
CHO-S X was generated by transfecting 4 μg of pTetOne vector 
(Clontech), containing cDNA for the human XBP1s sequence, 
into CHO-S cells (Life Technologies), co-transfected with 200ng 
of a linear selectable marker for puromycin (a vector:marker ratio 
of 20:1), with 4.2 μl of the transfection reagent NovaCHOice 
(Novagen). Transfected cells and untransfected control cells were 
grown in a 6 cm diameter dish in adherent culture, and after 
24 h of growth were trypsinised and 1/10 of the cells were trans-
ferred to a 15 cm dish and grown in 20 ml medium containing 
12.5 μg/ml puromycin. The transfected cells were grown for 
approximately 10 days, refreshing the selection medium every 
3–4 days. Colonies were identified and removed from the dish 
using trypsin-soaked cloning discs and transferred into the wells 
of a 12 well plate, with one colony per well. The clones were 
grown under selection for another 3–5 days until the well was 
confluent, then the surviving clones were transferred into T25 
flasks and later T75 flasks. To generate the CHO-S XB cell line, 
CHO-S X cells were transfected with a BFP construct18 using 
the same method as described above. The construct contained 
a G418 resistance gene, so the linear selectable marker was 
not required. Transfected cells were maintained under the dual 
selection of both 12.5 μg/mL puromycin and 2 mg/mL G418 
      Amendments from Version 1
This new version includes an additional Figure 5 which addresses 
one of the major comments raised by the reviewer. Additional 
text is included in the Results section to describe this experiment 
and the Discussion has been modified slightly to reflect the 
conclusions. We have added a new author, Marcel van Lith, who 
carried out this additional experiment.
See referee reports
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(Promega) to maintain the BFP construct. Successful integration of 
the gene of interest was confirmed by western blotting.
Maintenance of cell lines
CHO-S and CHO-S XB cells were grown in DMEM supple-
mented with 10% foetal bovine serum (FBS), 2mM glutamine, and 
non-essential amino acids at a working concentration of 10 μM 
for each amino acid (Gibco). Cells were grown as an adherent 
culture and split every 3–4 days using a standard trypsin protocol.
XBP1 splicing assay
RNA was extracted from stress treated cells using Trizol Reagent 
(Ambion), following the manufacturer’s recommended protocol. 
RT-PCR was either carried out using the AccessQuick RT-PCR 
kit (Promega) or first strand cDNA was synthesised using Super-
script II Reverse Transcriptase (Invitrogen) with oligo dTs 
(Invitrogen), according to the manufacturer’s specifications. 
cDNA for endogenous XBP1 was amplified using primers 
designed using CLC Genomics Workbench (v6) (RRID:SCR_
011853) to be specific to the Chinese hamster XBP1 sequence, 
(5’-CGCTTGGGAATGGATG-3’ and 5’- CAGGGTCCAACTT-
GTCC-3’; Sigma-Aldrich). The PCR reaction yielded a 247 bp 
fragment for XBP1u and a 215 bp fragment for XBP1s, plus a 
hybrid band of approximately 280 bp following electrophoresis 
through a 2% agarose gel. Both endogenous and exogenous XBP1 
were amplified simultaneously with a second, less specific set of 
primers, which can anneal to either the Chinese hamster or the 
human XBP1 sequence, 5’- ACAGCGCTTGGGGATGGATG-3’ 
and 5’- TGACTGGGTCCAAGTTGTCC-3’ (Sigma-Aldrich). 
PCR using these primers yielded the same fragments as the previ-
ous primer set, but with the addition of a fragment of 221 bp for 
exogenous XBP1s. Primers used for actin were 5’-CCACACCT-
TCTACAATGAGC-3’ and 5’-ACTCCTGCTTGCTGATCCAC-3’. 
PCR was performed with Accuzyme DNA polymerase (Bioline) 
with an initial melting step of 95°C for 5 min; then 35 cycles of 
95°C for 45 s, an annealing step for 45 s, and 72°C for 45 s; fol-
lowed by a final elongation step of 72°C for 10 min. The endog-
enous only primers used an annealing temperature of 60°C and the 
exogenous/endogenous primers used 62°C. For quantification, sam-
ples were separated on a 10% TBE polyacrylamide gel (BioRad) 
and analysed using Image J (v1.51q): RRID:SCR_003070.
Cell lysis
After removing culture medium from the 6 cm diameter dish, 
the cells were washed with 20 mM NEM in PBS for 10 min. This 
was removed and 120 μl lysis buffer (50 mM Tris-HCl buffer 
containing 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 4mM 
NaF) was added to the monolayer and the cells were scraped 
into the buffer. This suspension was left on ice for 10 min, 
centrifuged at maximum speed for 10 min and the supernatant was 
extracted.
SDS PAGE
Crude lysates were mixed with 0.2 M Tris-HCl (pH 6.8) con-
taining 10% (w/v) SDS, 20% (v/v) glycerol and 0.05% (w/v) 
bromophenol blue (sample buffer) in a 4:1 ratio of lysate to 
sample buffer. Dithiothreitol (DTT) was added as a reducing agent 
at a working concentration of 20 mM. Polyacrylamide gels were 
loaded with 20–30 μl of this sample mixture and run at 20 mA 
per gel.
Western blot
After separation, the samples were transferred to a nitrocellulose 
membrane (GE Healthcare) by wet transfer for 1 h at 250 mA using 
25 mM Tris-HCl containing 200 mM glycine, 3.5 mM SDS and 
20% (v/v) methanol. The blots were blocked in 5% (w/v) non-fat 
milk powder (Marvel) in 50 mM Tris-HCl buffer (pH 7.5) contain-
ing 150 mM NaCl and 0.1% (v/v) Tween (TBST) for 1 h. Primary 
antibodies were diluted in TBST and incubated overnight. Washes 
were performed three times for 10 min in TBST. Secondary 
antibodies were diluted in TBST and incubated for 1 h, and the blots 
shielded from light throughout the incubation. Blots were devel-
oped using the Odyssey SA scanner (Licor). The following primary 
antibodies were used: rabbit polyclonal anti-PDI19, 1:500; rabbit 
polyclonal anti-XBP1S (Biolegend, Cat# 619502, RRID:AB_
315907), 1:500; rabbit monoclonal anti-PERK, (Cell Signalling, Cat# 
3192 RRID:AB_2095847), 1:1000; mouse monoclonal anti-GAPDH, 
(Ambion, Cat# AM4300, RRID:AB_437392), 1:10000; rabbit 
polyclonal anti-actin, (Sigma-Aldrich Cat# A2103, RRID:AB_
476694), 1:500. The following secondary antibodies were used: 
donkey polyclonal anti-mouse 680RD, (LI-COR Biosciences 
Cat# 926-68072, RRID:AB_10953628) 1:10000; donkey polyclonal 
anti-mouse 800CW (LI-COR Biosciences Cat# 926-32212, RRID:
AB_621847), 1:10000; donkey polyclonal anti-rabbit 680RD, (LI-
COR Biosciences Cat# 926-68073, RRID:AB_10954442), 1:10000; 
donkey polyclonal anti-rabbit 800CW (LI-COR Biosciences 
Cat# 926-32213, RRID:AB_621848), 1:10000.
ER Tracker treatment
ER Tracker Green BODIPY FL Glibenclamide (Molecular Probes) 
was dissolved in DMSO to a 1 mM stock concentration. Treated 
cells were stained with 250 nM ER Tracker in Hank’s Balanced 
Salt Solution (HBSS) for 30 min, then trypsinised and resuspended 
in DMEM.
ER stress treatments
Dithiothreitol (DTT) (Melford Labs) was prepared as 1 M stock 
in water and used at a 2.5 mM working concentration. Thapsi-
gargin (Sigma-Aldrich) was prepared as a 2 mM stock in DMSO 
and used at 4 μM. Tunicamycin (Sigma-Aldrich) was prepared as a 
10 mg/mL stock in DMSO and used at 10 μg/mL. PERK inhibi-
tor (Tocris) was prepared as a 10mM stock in DMSO and used at 
2.5 μM. Treatments were added for 3 h to cells that had been 
pretreated with doxycycline for 48 h.
Flow cytometry
Cells were washed once in HBSS then run on a FACS Canto II flow 
cytometer (BD Biosciences) in HBSS. ER Tracker Green has an 
excitation at 504 nm and emission at 511 nm, which can be detected 
using the FITC filter on the flow cytometer. The data obtained was 
analysed using Flowing Software v2.5.1 (Turku Bioimaging).
Results
To investigate the consequence of overexpression of human XBP1s 
in CHO-S cells, we created a stable cell-line expressing XBP1s 
mRNA under the control of a doxycycline inducible promoter. 
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Figure 1. Induction of XBP1S expression in CHO-S XB cells. 
Western blot of lysates from CHO-S XB cells either uninduced or 
induced with doxycycline (Dox) for 3 days, probed with anti-XBP1s 
and anti-GAPDH as indicated. The blot is representative of the 
results obtained from three separate experiments.
Figure 2. Consequence of XBP1s expression on XBP1u splicing in cell lines following endoplasmic reticulum stress. (A) Schematic 
of the three possible cDNA products generated by primers that flank the XBP1 spliced intron (indicated in grey). Single stranded cDNA can 
anneal to either its complementary strand to generate double stranded XBP1u and XBP1s products, or generate a hybrid, XBP1h, formed 
from one strand XBP1u and one strand XBP1s. Of these three PCR products, XBP1s migrates the furthest on an agarose gel, followed by 
XBP1u and then by XBP1h, leading to the appearance of three distinct DNA bands. Adapted from 21. (B–E) XBP1 splice assay of cDNA 
extracted from either (B,D) CHO-S or (C,E) CHO-S XB cells treated with doxycycline (Dox; for 3 days) and/or tunicamycin (Tn; for 3 h) as 
indicated. PCR reactions contained primers that anneal only to the endogenous CHO XBP1 sequence (B,C) or primers that anneal to both 
the endogenous sequence and the exogenous XBP1s transcripts (D,E). The experiment was performed at least three times, data from a 
representative experiment is shown.
No XBP1S was detected unless doxycycline was included in the 
medium (Figure 1). Such tight regulation of expression allowed 
us to evaluate the effect of overexpression of XBP1s in the same 
cell line simply by culturing cells in the presence or absence of 
doxycycline. Interestingly additional bands at about 70 and 
100 kDa can be observed which are specific to the induced sam-
ple. Similar species have been reported and are thought to represent 
XBP1S that has undergone SUMOylation20.
To study the activation of IRE1α RNase activity, we assessed the 
cleavage of XBP1u mRNA before and after induction of human 
XBP1s expression, using an RT-PCR assay21. By designing prim-
ers that flank the XBP1 spliced intron, cDNA derived from XBP1s 
and XBP1u transcripts can be amplified by PCR and distinguished 
from each other by a subtle, 26bp difference in product size when 
run on an agarose gel. This assay is also known to generate a third 
PCR product, shown diagrammatically (Figure 2A), which is 
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thought to be a hybrid double-stranded cDNA product consisting 
of one strand XBP1s and one strand XBP1u. This hybrid product 
migrates above double-stranded XBP1u on an agarose gel due to its 
bulkier structure21. Two sets of primers were designed for the assay: 
the first set was designed to only anneal to the endogenous ham-
ster sequence of XBP1, and these primers were used to quantify 
only endogenous XBP1s and XBP1u. The second set was designed 
to bind to both forms of endogenous CHO XBP1, and also to the 
exogenous human XBP1s transcript, allowing visualisation of all 
forms of XBP1 present in the cell.
In the absence of cell-stress, the endogenous XBP1 mRNA in 
CHO-S cells was present as a mixture of unspliced and hybrid 
forms (Figures 2B and D). This result is consistent with a basal 
level of UPR signalling reported to be active under normal physi-
ological conditions22. As expected, there was no change in the splic-
ing pattern following treatment with doxycycline, indicating that 
this chemical alone does not induce the UPR. Following treatment 
with the ER stress inducer tunicamycin, all of the XBP1 mRNA 
was converted to either the spliced or hybrid form indicative of a 
strong UPR (Figures 2B and D). The splicing pattern of endog-
enous XBP1 mRNA in CHO-S XB cells in the absence of doxy-
cycline, with or without cell stress was similar to that in CHO-S 
cells (Figure 2C). However, in the absence of cell stress incuba-
tion with doxycycline to induce XBP1s expression prevented any 
splicing of endogenous XBP1 mRNA, as evidenced by the absence 
of the hybrid form. Doxycycline induced expression of exogenous 
XBP1s, as seen by the presence of XBP1s when primers recog-
nising both the human and hamster XBP1 were used in the assay 
(Figure 2E). We consistently observed an increase in expression 
of XBP1u following induction of XBP1s expression, indicat-
ing the upregulation of XBP1u expression by XBP1s, as shown 
previously21,23. Under conditions of ER stress XBP1 mRNA was 
efficiently spliced in the absence of doxycycline, but this splic-
ing was dramatically repressed after doxycycline treatment 
(Figure 2C). This result indicates that XBP1 splicing by IRE1α is 
largely prevented in cells overexpressing XBP1s.
To determine whether there was a correlation between the induc-
tion of expression of exogenous XBP1s and the repression of 
IRE1α cleavage of endogenous XBP1 mRNA, we titrated the 
amount of added doxycycline to induce increasing amounts of 
exogenous XBP1s. The effect on cleavage of endogenous XBP1 
mRNA became apparent after treating with 50 ng/ml of doxycy-
cline both in the absence or presence of tunicamycin-induced ER 
stress (Figures 3A and B). The effect increased with increasing 
concentrations of doxycycline with the greatest repression being 
most apparent at 1000 ng/ml in the presence of tunicamycin. When 
the presence of exogenously expressed XBP1s was evaluated using 
primers that amplify endogenous and exogenous XBP1, a clear 
increase in the XBP1s signal was observed at 50 ng/ml, which 
increased in intensity up to the highest concentration of doxy-
cycline used (Figure 3C). These results show a clear correlation 
between XBP1s expression and the repression of IRE1α-mediated 
cleavage of endogenous XBP1.
The expression of exogenous XBP1s should lead to the up- 
regulation of a number of proteins that are known to alleviate ER 
stress. Hence, the expression of XBP1s could prevent or suppress 
the tunicamycin-mediated activation of IRE1α, thereby repress-
ing its RNase activity. To determine the consequence of XBP1s 
expression on ER expansion, we stained cells with ER Tracker, 
a dye that binds to potassium channels prominent at the ER 
membrane24. Green fluorescence per cell was seen to increase 
following doxycycline treatment in CHO-S XB but not CHO-S 
cells, as quantified by FACS analysis (Figure 4A). This result indi-
cates that the expression of exogenous XBP1 does indeed cause 
an expansion in the ER, as seen previously when XBP1s is over-
expressed in CHO cells25. To determine whether XBP1s expres-
sion leads to a suppression of other branches of the UPR, we 
Figure 3. Inhibition of XBP1 splicing correlates with the amount of XBP1S. XBP1 splice assay of cDNA from CHO-S XB cells induced 
for 3 days with a range of doxycycline (Dox) concentrations, either not treated with tunicamycin (Tn) (A,C), or treated with 10µg/mL Tn for 
3 h. Primers specific for endogenous XBP1 (A,B) or endogenous and exogenous XBP1 (C) were used. The experiment was performed 
twice, data from a representative experiment is shown.
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evaluated the activation of PERK, indicated by autophosphorylation. 
PERK phosphorylation was assayed by a shift in electrophoretic 
mobility to a slower migrating form after UPR induction, exempli-
fied after treatment with DTT or the presence of a PERK kinase 
inhibitor26 (Figure 4B). There was no effect on PERK 
phosphorylation after treatment with a variety of UPR inducers 
(DTT, thapsigargin or tunicamycin) in the presence or absence 
of doxycycline in CHO-S XB cells. This result indicates that 
there is still a robust UPR activated following treatment with 
tunicamycin in cells overexpressing XBP1s as judged by PERK 
phosphorylation.
To further evaluate the relative effect of exogenous XBP1s 
expression on Ire1α or PERK function we monitored their acti-
vation over a range of tunicamycin concentrations (Figure 5). 
To allow more accurate quantification of endogenous XBP1 splic-
ing we separated the PCR products by PAGE gels allowing a 
clear separation of the spliced and unspliced forms (Figure 5A). 
Following quantification we observed that endogenous XBP1 
splicing was efficient in the absence of exogenous XBP1s expres-
sion reaching a maxima at concentrations above 5μg/ml tunicamy-
cin. Splicing was dramatically repressed at all concentrations of 
tunicamycin when tested in the presence of exogenous XBP1s 
(Figure 5C). Interestingly, while the response to the inducer was 
repressed the sensitivity was similar with splicing occurring at 
1μg/ml tunicamycin in the absence or presence of exogenous XBP1s. 
PERK was almost completely activated at the lower concentra-
tions of tunicamycin (1μg/ml) in the presence or absence of XBP1s 
expression with no differences either in the sensitivity or level 
of the response (Figure 5B, D). This result demonstrates that the 
differential effect of UPR induction on IRE1/PERK activation is 
not due to differences in their sensitivity to the inducer, rather it 
suggests that overexpression of XBP1s suppresses the IRE1α 
response while not effecting PERK. 
Figure 4. PERK activation is unchanged by overexpression of XBP1S. (A) Flow cytometry analysis of fluorescence from CHO-S and 
CHO-S XB cells stained with fluorescent ER Tracker dye. Samples were either treated with doxycycline (Dox) for 3 days (red) or left 
untreated (blue). (B) Western blot of lysates from CHO-S XB cells that were either untreated (UT), treated with a reducing agent (DTT) or with 
an inhibitor of PERK kinase activity (PERKi). Blots were probed with anti-PERK to display the extent of PERK phosphorylation. (C) Anti-PERK 
western blot of CHO-S XB cells induced with Dox and subsequently treated with DTT, thapsigargin (Tg) or tunicamycin (Tn). Experiment 
(A, B and C) were performed twice.
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Figure 5. Differential effect of PERK and Ire1 activation is not due to differences in sensitivity to UPR induction. (A) Expression of 
spliced exogenous XBP1 in CHO XB cells was induced by incubation with 1µg/ml doxycycline for 48 hours (refreshed after 24 hours). The 
cells were incubated with a tunicamycin (TM) concentration range as indicated for three hours. The samples were analysed for unspliced 
(XBP1u) and spliced (XBP1s) by RT-PCR, with actin as loading control (markers indicated as base pairs on the right). (B) In a separate 
experiment, induced and uninduced CHO XB cells were treated with the same tunicamycin concentration range as in (A) for three hours and 
analysed by SDS-PAGE and Western blot with an anti-PERK and anti-actin antibody (molecular weight markers indicated in kDa on the right). 
(C and D) Quantification of spliced CHO XBP1 and phospho-PERK of (A) and (B), respectively. The results in C) and D) are from a single 
experiment. The experiments in A) and B) were carried out three times with consistent results.
Discussion
Activation of the IRE1α branch of the UPR can lead to a vari-
ety of outcomes based on regulation of its RNase activity27. This 
activity is tightly controlled by a number of mechanisms, including 
the transcript and protein levels of IRE1α, changes to its quaternary 
structure and by its phosphorylation and redox state. Our results 
indicate an additional mechanism of IRE1α feedback regulation 
involving XBP1s, which is able to repress RNase activity towards 
XBP1u. This regulation was revealed upon overexpression of 
XBP1s and occurred in the absence and presence of ER stress.
Overexpression of XBP1s leads to high levels of expression 
of XBP1S protein, to the expansion of the ER and an increased 
expression of secreted proteins25,28. Preconditioning the ER to stress 
by XBP1s expression could prevent IRE1α activation, thereby 
repressing splicing of endogenous XBP1u. However, we showed 
that robust activation of PERK still occurs in cells overexpressing 
XBP1s upon ER stress. In addition the effect of exogenous XBP1s 
expression was to suppress IRE1α activity rather than alter its 
sensitivity towards UPR induction. As the mechanism for PERK 
and IRE1α activation requires BiP dissociation it seems unlikely 
that the suppression of Ire1α is due to increased levels of BiP. 
Hence, activation of IRE1α should occur even in the presence 
of XBP1s. The repression of IRE1α ability to splice XBP1u is, 
therefore, most likely to occur downstream of its activation during 
stress conditions.
Activation of IRE1α leads to its phosphorylation, which has been 
shown to promote dimerisation of its cytosolic domain29. This 
suggests that phosphorylation activates IRE1α, whereas a 
phosphatase could be responsible for attenuating IRE1α. One 
phosphatase, PP2Ce, has been suggested to perform this role15; 
however, the promoter for this gene does not display the ERSE, 
ERSE-II or UPRE consensus sequences characteristic of genes 
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upregulated by XBP1s30,31. Also, it has been shown that hyper- 
phosphorylation rather that dephosphorylation of yeast IRE1 is 
required to deactivate this protein32. Nevertheless, the possibility 
remains that an XBP1s-inducible phosphatase could attenuate the 
activity of IRE1α during prolonged induction of the UPR.
Alternatively, XBP1s could block the initial phosphorylation and 
dimerisation of IRE1α in order to reduce the overall intensity of 
IRE1α signalling. In support of this hypothesis, it was reported 
that XBP1s works in complex with Sec63 and BiP to negatively 
regulate IRE1α autophosphorylation33. A mouse Sec63 knockout 
cell line was shown to constitutively activate IRE1α phosphoryla-
tion, regardless of the presence of ER stress. Intriguingly, this study 
revealed that the overexpression of XBP1s in the Sec63 knock-
out cell line was able to abolish the activation of IRE1α almost 
entirely, even in the presence of tunicamycin, indicating that Sec63 
and XBP1s work in concert to regulate IRE1α phosphorylation. 
However, this study did not examine the effect of XBP1s 
overexpression on IRE1α activation in a cell line with physi-
ological levels of Sec63; circumstances that would be closer to the 
conditions used in the results reported here.
The abundance of IRE1α can be modulated by proteosomal 
degradation initiated by ubiquitination by the E3 ubiquitin ligase 
synoviolin (SYVN1), otherwise known as the ERAD compo-
nent HRD134. The ubiquitination of BiP-bound IRE1α monomers 
by SYVN1 leads to its dislocation from the ER and degradation 
by the proteasome. Under normal physiological conditions, BiP- 
bound IRE1α is continually degraded by ERAD, but the detach-
ment of BiP allows for IRE1α to bypass interaction with SYVN1 
and undergo accumulation and activation35. Like other components 
of ERAD, SYVN1 is upregulated by XBP1s so it can be assumed 
that CHO-S XB would display high levels of SYNV1. This could 
lead to a reduction in IRE1α protein in XBP1s overexpressing 
cells; however, as only BiP-bound IRE1α is targeted for ERAD it 
is only this inactive form that would be affected by XBP1s upregu-
lation, and not activated dimers. However, there is precedent for 
a reduction in total IRE1α unrelated to proteasomal degradation 
in the presence of stress. Heat shock treatment was shown to 
deplete IRE1α in a range of mammalian cell lines in a manner 
that could not be blocked by a proteasome inhibitor36. The UPR 
was activated in these cells, indicated by the presence of IRE1α 
phosphorylation and other UPR hallmarks, but the specific 
mechanism for the degradation of IRE1α could not be clarified, 
and was attributed to an unknown method of suppressing extreme 
UPR signalling. It is possible that this mechanism could be 
mediated via XBP1s.
While we have noted here that XBP1s overexpression repressed 
XBP1u splicing, we have not investigated whether there is any 
suppression or even activation of activity towards other RNA 
substrates. It has been shown previously that overexpres-
sion of XBP1s had no effect on cell viability under non-stress 
conditions12. Hence, under these conditions there was no suppres-
sion or activation of IRE1α RNase activity towards substrates 
other than XBP1u. It remains to be determined whether under 
stress conditions and in the presence of excess XBP1s, repression 
of IRE1α RNase activity extends to all mRNAs not just XBP1u.
Dysregulated IRE1α is a known contributing factor to a number 
of diseases, including multiple myeloma37, epithelial cancers38, 
Parkinson’s disease39 and inflammatory bowel disease40. Hence, 
increased knowledge of the regulatory mechanisms controlling 
IRE1α activity will help in understanding the pathogenesis of these 
diseases, as well as improving any therapeutic intervention.
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The weak protein bands seen in figure 1 that have a slower modility than XBP1 are indeed
only present in the induced sample and are identifed with the antibody as contaning
XBP1. It has been show previously that XBP1 can be modified by SUMOylation so we
presume that these additional protein bands are due to this modification. We include a
sentence in the results to suggest this possibility.
 
The differential effect of exogenously expressed XBP1 has now been tested by determining
the effect of a range of tunicamycin concentrations on XBP1 splicing or PERK
activation. This additional experiment indicates that Ire1 is activated and as sensitive to
UPR inducers in the presence of exogenous XBP1 as in its absence, but its splicing activity
is dramatically repressed. This results does not address the consequence of BiP
dissociation from Ire1 or PERK directly but it clarifies that there is a supression of activity
rather than activation. 
 
We have now carried out a repeat of Figure 4C with a loading control. (see ORF (DOI:
10.17605/OSF.Io/BGCDE;)
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 No competing interests were disclosed.Competing Interests:
 06 June 2017Referee Report
doi:10.21956/wellcomeopenres.12708.r23240
   Stefan J. Marciniak
Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
Protein misfolding in the endoplasmic reticulum (ER), ER stress, activates an unfolded protein response
Page 13 of 16
Wellcome Open Research 2017, 2:36 Last updated: 17 OCT 2017
 1.  
2.  
3.  
Protein misfolding in the endoplasmic reticulum (ER), ER stress, activates an unfolded protein response
(UPR) . This UPR defends the cell by attenuating protein synthesis, enhancing ER chaperone levels and
activity, and increasing ER-associated protein degradation. Three signalling pathways make up the UPR,
each initiated by a separate ER stress sensor, IRE1α, PERK, and ATF6. These differ in their downstream
signalling and in their kinetics of activation and deactivation . Activated IRE1α initiates the splicing of the
mRNA encoding XBP1 . Unspliced XBP1 mRNA encodes an inactive protein, XBP1u, while spliced
XBP1 mRNA encodes an active transcription factor, XBP1s.  XBP1s activates genes that increase ER
chaperone expression and cause expansion of the ER.
In the study of Chalmers  , cells were generated that express active XBP1s protein in response toet al
treatment with doxycycline. This caused expansion of the ER, consistent with induction of the known gene
expression programme of XBP1s. When forced to express exogenous XBP1s, these cells also showed
reduced splicing of endogenous XBP1u when treated with tunicamycin, an inhibitor of glycosylation
commonly used to induce ER stress. In contrast, activation of PERK in response to ER stress-inducing
agents (DTT, tunicamycin, or thapsigargin) appeared to remain unaffected.
This is a well-written paper. The proposed direct feedback mechanism linking XBP1s to inhibition of
XBP1u splicing would be an important finding if it could be demonstrated definitively; however, the current
version of the paper leaves a second (less interesting) mechanism still to be excluded.
Main concern
The authors suggest that XBP1s selectively blocks splicing of endogenous XBP1u, and that this does not
involve a simple generalised resistance of the ER to stress. The authors acknowledge the second
possibility in their discussion, but dismiss it because   PERK activation persists following induction of(i)
XBP1s and   PERK and IRE1α are known to share a similar mechanism of activation . However,(ii)
differences in the sensitivity of IRE1α and PERK to ER stress could account for their observations. If
PERK were to be more sensitive than IRE1α to ER stress, then induction of BiP (or any process
downstream of XBP1s that ameliorates ER stress) could block activation of IRE1α while leaving PERK
apparently unaffected. This would occur if the concentration of stressor used were to be above the
threshold required to activate PERK but below that required to activate IRE1α. To address this, ranges of
DTT, tunicamycin, and thapsigargin concentrations could be tested for their effects on IRE1α and PERK,
in the presence and absence of overexpressed XBP1s. If a selective negative feedback mechanism
exists linking XBP1s to the inhibition of XBP1u splicing, then the EC50s of these agents will increase only
for the activation of IRE1α.
Minor concerns
It is unclear why the phosphorylation of IRE1α has not been measured. This would help determine
at what stage XBP1s antagonizes IRE1α signaling.
 
The kinetics of activation and deactivation of IRE1α and PERK differ significantly . Have these
been examined in this system?
 
Does expression of XBP1s inhibit the activity of an IRE1α cytosolic domain activated
independently of ER stress, e.g. the IRE1 constructs described in refs ?
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The main concern of this reviewer was that the results could be explained if the sensitivity of Ire1 or
PERK to UPR induction was different so that, at the concentrations we are using, there could be a
differential effect. We carried out the experiment suggested by the reveiwer, i.e. a titration of the
response to tunicamycin in the absence or presence of exogenous XBP1. We include the result as
a new figure in our revised version (Figure 5). Interestingly the result demonstrates that the
exogenous XBP1 suppresses Ire1 splicing activity but does not alter its sensitivity towards the
inducer. The conclusion is that Ire1 can still be activated but its activity is in some way inhibited by
the presence of exogenous XBP1. No effect was seen for PERK which showed the same
sensitivity to the UPR inducer in the presence or absence of exogenous XBP1.
The minor concerns of the reviewer can be addressed as follows:
We have tried several commercial antibodies to IRE1α but none recognise the hamster
protein. We can indirectly conclude that Ire1α is activated from the splicing assays carried
out but cannot assay its phosphorylation status.
 
We have not carried out an analysis of the kinetics of activation or inactivation.  As our
comparison is between the absence of presence of exogenous XBP1, we focused on the
difference between the splicing activity towards endogenous XBP1 in this paper. 
 
We have not carried out the experiments with the cytosolic domains of Ire1α suggested by
the reviewer.  We do know that in the absence of an exogenous agent to activate the UPR
we still see a supression of XBP1 splicing in the presence of exogenous XBP1. This is likely
due to a low level of ER stress that occurs even in the absence of external agents. 
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